National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022-Reference-Cited by-同舟云学术

National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022

Published:2023-12 Issue:12 Volume:5 Page:100897
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Li Wenhao^ORCID,Sheridan David,McPherson Stuart^ORCID,Alazawi William^ORCID,Abeysekera Kush,Marjot Tom,Brennan Paul,Mahgoub Sara,Cacciottolo Tessa,Hydes Theresa,Hardy Tim,McGinty Gio,Tavabie Oliver,Cathcart Jennifer,Premathilaka Chirantha,Mukhopadhya Ashis,Bhat Arshiya,Begum Shahnaz,Abushaban Bashar,Bhuva Meha,Sinclair Sophie,Leith Damien,McCulloch Cullen,Leithead Joanna,Fox Richard,Shah Muhammad Haris,Campbell Eugene,Brown Edward,Mansour Dina,Shah Fatma,Allison Michael,Chan Jonathan,Roberts Victoria,Appanna Gautham,Mandour Mandour Omer,Slee Georgina,Wong Vicki,Kotha Sreelakshmi,Pekarska Katrina,Parker Richard,Sieberhagen Cyril,Ngan Thomas,Asilmaz Esra,Miller Hamish,Cobbold Jeremy,Crocombe Dom,Tsochatzis Manolis,Tanwar Sudeep,Dias Aruna,Singh Gurmit,Agrawal Swastik,Chhabra Puneet,Gurung Amrita,Veettil Rajesh,Abeles Robin Daniel,Chatterjee Devnandan,Carbonell Michael,Mohamed Zameer,El-Sayed Ahmed,Johnson Amy,Leith Damien,Barclay Stephen,Kelly Katherine,Munonye Joshua,Coates Dominic,Bamidele Opeyemi,Johnston Thomas,Samuel David,Ball Belinda,Arscott-Samuel Rebecca,Hams Pamela,Armstrong Matthew,Elkhol Ayman,Shailesh Karanth,Bains Vikram,Manousou Pinelopi,Gupta Tarun,Than Sophia,Unitt Esther,Gordon Victoria,Wakefield Alice,Gilchrist Sian,Cozma Ioana,Saeed Sohaib,Umrani Salman,Olsen Kathryn

Funder

Medical Research Council

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference26 articles.

1. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review;Younossi;Hepatology,2023

2. Non-alcoholic fatty liver disease;Li;Clin Med (Northfield Il),2020

3. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up;Ekstedt;Hepatology,2015

4. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis;Taylor;Gastroenterology,2020

5. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications;Targher;Gut,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. #FGDebate: addressing regional variations in care and outcomes for patients with liver disease;Frontline Gastroenterology;2024-08-30

2. Statin prescriptions and progression of advanced fibrosis risk in primary care patients with MASLD;BMJ Open Gastroenterology;2024-07

3. Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge;Metabolism and Target Organ Damage;2024-06-26